Status:
COMPLETED
D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy
Lead Sponsor:
Wuhan Asia Heart Hospital
Conditions:
Atrial Fibrillation
Strokes Thrombotic
Eligibility:
All Genders
18-75 years
Brief Summary
This is a sigle-center, prospective study to evaluate the role of D-Dimer testing in patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy.
Detailed Description
Patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy was screened and signed to two group: Dabigatran group and Warfarin group. D-dimer test was analyzed before a...
Eligibility Criteria
Inclusion
- Non-valvular atrial fibrillation
- Receiving oral anticoagulation therapy and have good compliance
Exclusion
- Life expectancy less than 1 year
- Thrombosis or major bleeding history within 3 months
- Refusal to Participate
Key Trial Info
Start Date :
August 9 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
1194 Patients enrolled
Trial Details
Trial ID
NCT03280641
Start Date
August 9 2015
End Date
September 1 2017
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WAHH
Wuhan, Hubei, China, 430000